Merck Announces Voluntary Worldwide Withdrawal of VIOXX®
I remember using VIOXX® some years ago, I never felt very well taking it so I discontinued its use. It was a good decision as it is now being linked to an increased risk of heart attack and stroke.
WHITEHOUSE STATION, N.J., Sept. 30, 2004 – Merck &. Co., Inc. today announced a voluntary worldwide withdrawal of VIOXX® (rofecoxib), its arthritis and acute pain medication. The company’s decision, which is effective immediately, is based on new, three-year data from a prospective, randomized, placebo-controlled clinical trial, the APPROVe (Adenomatous Polyp Prevention on VIOXX) trial.